Advanced search
Publication Cover
Neuro-Ophthalmology Volume 44, 2020 - Issue 6
Submit an article Journal homepage
97
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Compressive Optic Neuropathy with a Concurrent Mutation of Leber’s Hereditary Optic Neuropathy: A Case Report

Yooyeon Parka Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaView further author information
,
Kyong Ohna Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaView further author information
,
Ye Jin Ahna Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaView further author information
,
Jinhee Jangb Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaView further author information
&
Shin Hae Parka Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaCorrespondence[email protected]
View further author information
Pages 387-390 | Received 01 Jul 2019, Accepted 07 Dec 2019, Published online: 28 Jan 2020

References

  • Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science. 1988;242:1427–1430. doi:10.1126/science.3201231.
  • Ran R, Yang S, He H, Ma S, Chen Z, Li B. A retrospective analysis of characteristics of visual field damage in patients with Leber’s hereditary optic neuropathy. Springerplus 2016 23;5(1):843. doi:10.1186/s40064-016-2540-7.
  • Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol. 2005;140:517–523. doi:10.1016/j.ajo.2005.03.017.
  • Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet. 1991;48:1147–1153.
  • Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet. 1992;51:1218–1228.
  • Yum HR, Chae H, Shin SY, Kim Y, Kim M, Park SH. Pathogenic mitochondrial DNA mutations and associated clinical features in Korean patients with Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2014 23;55(12):8095–8101. doi:10.1167/iovs.14-15311.
  • Liang M, Guan M, Zhao F, et al. Leber’s hereditary optic neuropathy is associated with mitochondrial ND1 T3394C mutation. Biochem Biophys Res Commun. 2009 5;383(3):286–292. doi:10.1016/j.bbrc.2009.03.097.
  • Matsumoto M, Hayasaka S, Kadoi C, et al. Secondary mutations of mitochondrial DNA in Japanese patients with Leber’s hereditary optic neuropathy. Ophthalmic Genet. 1999;20:153–160. doi:10.1076/opge.20.3.153.2281.
  • Puomila A, H¨am¨al¨ainen P, Kivioja S, et al. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007;15:1079–1089. doi:10.1038/sj.ejhg.5201828.
  • Majander A, Huoponen K, Savontaus ML, Nikoskelainen E, Wikstrom M. Electron transfer properties of NADH: ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett. 1991;292:289–292.
  • Hirai M, Suzuki S, Onoda M, et al. Mitochondrial DNA 3394 mutation in the NADH dehydrogenase subunit 1 associated with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 1996 27;219(3):951–955. doi:10.1006/bbrc.1996.0324.
  • Müller HL. Craniopharyngioma. Endocr Rev. 2014;35(3):513–543. doi:10.1210/er.2013-1115.
  • Mulliez E, Blanckaert M, Blanckaert J. Acute manifestation of LHON and coincidental finding of a pituitary adenoma: a case report. Bull Soc Belge Ophtalmol. 2000;277:35–42.
  • Cruz-Bermúdez A, Vallejo CG, Vicente-Blanco RJ, et al. Enhanced tumorigenicity by mitochondrial DNA mild mutations. Oncotarget 2015 30;6(15):13628–13643. doi:10.18632/oncotarget.3698.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.